BIO CEO & Investor Conference
Prostate Cancer R&D for Drugs Increases Alongside Disease
By Michael Harris
Tuesday, February 15, 2011
NEW YORK Prostate cancer is a burgeoning disease market, but a recent spate of promising clinical news from the drug development industry is also offering optimism for the potential for an equally growing market for drug approvals to address the disease.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.